⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Figure S7 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Austin K. Mattox Christopher Douville Yuxuan Wang Maria Popoli Janine Ptak Natalie Silliman Lisa Dobbyn Joy Schaefer Steve Lu Alexander H. Pearlman Joshua D. Cohen Jeanne Tie Peter Gibbs Kamel Lahouel Chetan Bettegowda Ralph H. Hruban Cristian Tomasetti Peiyong Jiang K.C. Allen Chan Y. M. Dennis Lo Nickolas Papadopoulos Kenneth W. Kinzler Bert Vogelstein

View at Publisher

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

Supplemental Figure 7. The amount of total cfDNA before and after surgery in patients with pancreatic cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mattox et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587523272 https://doi.org/10.1158/2159-8290.27026204.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S8 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer2024
2Figure S6 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer2024
3Figure S1 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer2024
4Figure S9 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer2024
5Figure S3 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer2024

Figure S2 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer2024
Data from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer2024
Supplementary Notes 1-5 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer2024